Acute lymphoblastic leukemia (ALL) blasts undergo migration into layers of bone marrow fibroblasts (BMF) in vitro, utilizing the ␤1 integrins VLA-4 and VL-5 as adhesion molecules. However, it has been unclear as to whether this is a selective process mediated by specific chemoattractant molecules, or simply a reflection of the highly motile nature of early B cell precursors. We further characterized this process using a transwell culture system, in which the two chambers were separated by an 8 m diameter microporous membrane, through which leukemic cells could move. When a BMF layer was grown on the upper surface of the membrane there was an 84.1% reduction in transmigration of the human pre-B ALL cell line NALM-6 into the lower chamber, compared to control membrane with no BMF layer. Localization of leukemic cells under the BMF layer was confirmed ultrastructurally, suggesting the possibility that the migration of leukemic cells was directed by a chemotactic agent secreted by BMF. The involvement of the chemokine stromal cell-derived factor-1 (SDF-1) in this process was next investigated. BMF were shown to express m-RNA for SDF-1. Addition of SDF-1 at 100 ng/ml into the lower chamber increased transmigration of NALM-6 across the membrane by 2.2-fold, and also induced a 1.4-to 6.1-fold increase in movement of NALM-6 through a BMF layer into the lower chamber. The receptor for SDF-1, CXCR4, was demonstrated by flow cytometry on all 10 cases of precursor-B ALL analyzed, as well as on NALM-6, KM-3 and REH lines. An inhibitory antibody to CXCR4 was able to block the migration of NALM-6 cells into BMF monolayers grown on plastic by 51%, and in nine cases of ALL by 8-40%, as well as partially inhibit transmigration of leukemic cells through BMF layers along an SDF-1 concentration gradient. These results confirm that precursor-B ALL cells selectively localize within bone marrow stroma in vitro, and that this process is partially due to the stromal chemokine SDF-1 binding to its receptor CXCR4 on leukemic cells. SDF-1 may be important in influencing the localization of precursor-B ALL cells in marrow microenvironmental inches which regulate their survival and proliferation. Leukemia (2000) 14, 882-888.
Introduction
The microenvironment of the bone marrow plays a crucial role in regulating the survival, proliferation, and differentiation of both normal hemopoietic cells and acute leukemia cells. [1] [2] [3] [4] [5] Localization of hemopoietic progenitors and leukemic cells involves interaction of leukocyte adhesion molecules with counterligands present on bone marrow stromal cells and extracellular matrix. [4] [5] [6] [7] Adhesion of normal CD34-positive bone marrow cells and acute leukemia cells to bone marrow stroma in vitro has been shown to involve the ␤1 integrins VLA-4 (CD49d) and VLA-5 (CD49e) as well as the ␤2 integrin LFA-1 (CD11a), while other adhesion molecules may also be implicated. [7] [8] [9] In addition, specific homing molecules 10 and concentration gradients of chemotactic factors 11 or cytokines may be involved in localization of primitive normal and leukemic hemopoietic cells to the marrow microenvironment.
Adhesion of human lymphoid leukemia cells to the surface of bone marrow stromal layers in vitro is rapidly followed by tunnelling into and migration beneath the stromal layers. [12] [13] [14] This process has been demonstrated to be dependent on the presence of VLA-4 and VLA-5, and is largely specific for the precursor-B form of acute lymphoblastic leukemia (ALL) and related cell lines. [12] [13] [14] In contrast, acute myeloid leukemia (AML) cells do not migrate into marrow stromal layers in vitro, although ultrastructural studies have shown evidence of leukemic cell motility. 14, 15 This raises the question as to whether the migration of precursor-B ALL cells into marrow stroma simply reflects an inherently greater level of motility than AML, or is selective and related to the presence of a chemotactic factor(s) secreted by stromal cells and concentrated in their local microenvironment. One potential chemoattractant for precursor-B ALL cells is the chemokine stromal cellderived factor-1 (SDF-1), a recently described member of the CXC family of chemokines which includes interleukin-8. 16, 17 In addition to acting as a chemoattractant for CD34-positive hematopoietic cells, monocytes and T lymphocytes, 18, 19 SDF-1 is a potent chemokine for B cell progenitors. SDF-1 knockout mice have severe defects in B lymphopoiesis, suggesting that this chemokine plays a vital role in normal early B cell development through trafficking of progenitors to appropriate bone marrow microenvironmental niches. 20 SDF-1 binds to the cellular receptor CXCR4, which is expressed on normal CD34-positive bone marrow cells. 21 However, the expression of CXCR4 on precursor-B ALL, and the effects of SDF-1 on their migratory behavior have not been reported to date.
In order to investigate this further, we used a transwell culture system, containing a membrane with 8 micron pores through which cells are able to move. By interposing a bone marrow stromal layer on one side of the membrane, we were able to analyze the degree to which ALL cells are selectively retained within bone marrow stroma, and examine the effects of SDF-1 on their migration.
Materials and methods

Leukemic cells
Leukemic cell lines used in this study included the human pre-B ALL lines NALM-6, REH, and KM-3, which were maintained in RPMI-1640 medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal calf serum (FCS; ICN Biomedicals, Costa Mesa, CA, USA), L-glutamine, and antibiotics. Leukemic blast cells were obtained from untreated patients with acute leukemia, with informed consent and institutional ethics committee approval. Heparinized peripheral blood or bone marrow aspirate samples were diluted with sterile medium and centrifuged on Ficoll-Paque (Pharmacia, Uppsala, Sweden). Washed mononuclear cells were then cryopreserved in 10% dimethylsulphoxide, 20% FCS, and medium, prior to use.
Bone marrow fibroblasts
Bone marrow fibroblasts (BMF) were cultured from normal bone marrow mononuculear cells, as previously described. 8 
Flow cytometry
Immunofluoresent staining of cells and analysis was carried out as previously described. 9 Briefly, 1-2 × 10 5 leukocytes were incubated with titered amounts of CXCR4 monoclonal antibody, or isotype control, washed, reacted with sheep antimouse IgG conjugated with FITC (Silenus, Melbourne, Australia), and analyzed in a FACScan flow cytometer (Becton Dickinson).
Migration of leukemic cells into BMF layers
The ability of pre-B ALL cells to migrate into bone marrow stromal layers grown on plastic surfaces was assessed using adherent bone marrow fibroblasts. 2 × 10 4 BMF were seeded into 96-well flat-bottom tissue culture plates (Costar, Cambridge, MA, USA), and used 48-72 h later when confluent, as previously described.
14 Leukemic cells were labeled with 51 Na 2 CrO 3 , washed, and added at 2 × 10 5 /well to confluent BMF layers. Plates were incubated at 37°C for 5 h. The BMF layer was then washed to remove cells from the surface, then solubilized using Triton X-100, and counted in a gamma counter. The proportion of migrated cells was then compared to the total input number, as previously described. 14 
Transmigration assay
A transwell culture system was used to characterize the specificity of cell transmigration, and to evaluate the effects of chemokines and antibodies. BMF were seeded at 2 × 10 4 per well on to 8 micron microporous polycarbonate membranes (Costar), cultured for 48-72 h, and checked by light microscopy to ensure complete confluency. Coated membranes were then transferred into 24-well tissue culture plates (Costar) to separate the culture system into upper and lower compartments. 600 l of RPMI medium plus 10% FCS was Leukemia added to the lower chambers. 2 × 10 5 Na 2 CrO 3 -labeled leukemic cells (in 200 l medium) were then added to the upper compartment, and wells incubated for 5 h (37°C) in 5% CO 2 in air. In some experiments, SDF-1 (100 ng/ml) was added to the lower compartment to form a chemoattractant gradient, as previously described, 19 while in other assays leukemic cells were pre-incubated for 30 min with 4B4 (5 g/ml) or CXCR4 (50 g/ml) antibodies, before being added unwashed to the upper compartment. The contents of the lower compartments were collected, and cells migrating through the membrane from the upper chamber were quantitated in a gamma counter, and expressed as a percentage of total input cells in the upper chamber.
Electron microscopy
Ultrastructural studies of migrating leukemic cells were carried out as previously described. 14, 15 Briefly, leukemic cells were allowed to adhere to and migrate into BMF layers grown on microporous transwell membranes. The membranes were examined by light microscopy to assess areas of leukemic cell migration. Relevant foci were then carefully cut from the insert and divided into eight to 10 segments. The segments were stacked and embedded in 1% agar gel. The blocks were then post-fixed in osmium tetroxide 1%, stained en bloc with uranyl acetate 0.5%, dehydrated in serial concentrations of ethanol, and infiltrated through serial concentrations of Spurr resin according to standard techniques. Each block was then oriented in a Beem capsule, embedded in Spurr resin, thick sections (50 m) cut with a glass knife and viewed under a light microscope. After trimming the block, thin (90 nm) sections were cut on a Reichert ultracut E ultramicrotome, grid stained with Reynolds lead citrate, and viewed with a Philips CM10 transmission electron microscope (Eindhoven, The Netherlands).
Detection of m-RNA for SDF-1
Total RNA was isolated from human bone marrow fibroblasts using Total RNA isolation Reagent (Advanced Biotechnologies, Surrey, UK). Complementary DNA was then made by M-MLV reverse transcriptase (Promega, Madison, WI, USA), and PCR was performed for SDF-1␣ and ␤ forms, as well as to the common region of both forms using specific primers homologous to SDF-1 mRNA sequences, as follows: common region SDF-1 82-101/319-338; SDF-1 alpha 82-101/777-796: SDF-1 beta 82-101/861-880, according to previously published results. 22 PCR products were electrophoresed on 1% agarose gels, and visualized with ethidium bromide.
Statistics
Student's t-test was used to compare paired experiments.
Results
Effects of bone marrow fibroblasts on pre-B ALL migration
Using the transwell culture system, 27.2 ± 7.8% of NALM-6 cells were found to undergo transmigration into the lower compartment over 5 h (column 1, Table 1 ). The presence of a confluent BMF layer on the upper surface of the transwell membrane resulted in an 84.1 ± 10.6% (P р 0.03) reduction in NALM-6 transmigration (column 2, Table 1 ). Transmission electron microscopy studies on sections of these membranes showed that this reduction in transmigration through the membrane was due to retention of the leukemic cells underneath the BMF layer (Figure 1 ), in agreement with previous studies in our laboratory.
14,15
Figure 1
Ultrastructure of NALM-6 cell (n) which has migrated into a bone marrow fibroblast layer (b) established on microporous membrane (m). Magnification ×9450. 
Expression of m-RNA for SDF-1 by bone marrow fibroblasts
PCR for SDF-1 mRNA molecules on total RNA isolated from BMF revealed bands of characteristic molecular sizes for the ␣ and ␤ forms of SDF-1 (Figure 2, lanes 3 and 4) and the common region for both forms (lane 2, Figure 2 ). These results indicate that BMF express mRNA for SDF-1.
Expression and function of CXCR4 chemokine receptor on pre-B ALL cells
In order to determine whether the chemokine SDF-1 had an influence on the migration behavior of pre-B ALL cells in the above experiments, we first analyzed cells for expression of the receptor for SDF-1, namely CXCR4. As is evident from Table 2 , the majority of cells from three pre-B ALL lines and 10 cases of precursor-B ALL showed moderate to strong positivity for CXCR4 by flow cytometry ( Figure 3) . Next, we examined the effects of an inhibitory antibody to CXCR4 on pre-B cell migration into confluent layers of BMF in plastic tissue culture wells. As previously demonstrated, 14 approximately 30% of NALM-6 cells localize beneath confluent BMF monolayers within 5 h under these conditions.
Figure 3
Flow cytometry analysis of CXCR4 expression on pre-B ALL cells. (a) NALM-6; (b) precursor-B ALL case 10; (c) precursor-B ALL case 4. Solid tracing indicates negative isotype control.
Leukemia
This migration could be largely abolished by pre-incubation of the NALM-6 cells with antibody 4B4 (Table 3) , which binds to human ␤1 integrin and blocks initial adhesion of leukemic cells to the surface of BMF layers. [12] [13] [14] When NALM-6 cells were preincubated with an inhibitory antibody to CXCR4, a significant reduction in migration of cells into BMF layers (range 28 to 86%, mean 53.0 ± 17.5%; P р 0.001) was observed in seven separate experiments using different sources of BMF, although this reduction was not as great as that seen with anti-␤1 integrin antibody. Addition of CXCR4 antibody to anti-␤1 integrin had no apparent additional inhibitory effect compared to anti-␤1 integrin alone (Table 3) . A polyclonal antibody to SDF-1 was also able to significantly inhibit migration of NALM-6 into BMF in one of two experiments (Table 3) .
Similarly, partial inhibition of migration of leukemic cells from nine cases of precursor-B ALL into BMF layers was seen using preincubation with CXCR4 antibody (Table 4) . Inhibition ranged from 14.5 to 40.9% in seven cases, and reached significance in five of these cases, while two cases showed Ͻ10% inhibition.
Chemotactic effects of SDF-1 on pre-B ALL
In order to further clarify the role of SDF-1 as a putative chemoattractant for pre-B ALL cells, the migration of NALM-6 cells through a microporous membrane into a lower chamber with or without the addition of SDF-1 was examined (Figure 4 ). SDF-1 at either 100 or 200 ng/ml induced a significantly greater degree of migration of NALM-6 over 5 h than medium alone. Interestingly, preincubation of NALM-6 with CXCR4 antibody only partially inhibited this chemotactic effect (Figure 4) .
Finally, the effects of SDF-1 and the blockade of its receptor on the transmigration of pre-B ALL cells through BMF layers were analyzed (columns 3 and 4, Table 1 and Table 5 ). In three separate experiments, SDF-1 at 100 ng/ml in the lower chamber was capable of inducing a significantly greater degree of migration of NALM-6 through the BMF layer, representing a 1.4-to 6.1-fold increase in migration in these three experiments (Table 1) . This effect could be partially blocked by preincubation with CXCR4 antibody. A similar picture was observed when six cases of precursor-B ALL were examined (Table 5 ). In three of six cases, SDF-1 induced a significant increase in transmigration of patient blast cells across a BMF layer, an effect that was fully or partially inhibitable by incubation of leukemic cells with CXCR4 antibody.
Discussion
This study has revealed two main new findings regarding the biology of pre-B ALL. Firstly, the double chamber system used to quantitate leukemic cell motility confirmed that ALL cells are selectively retained within a layer of bone marrow stromal cells. Previous studies have shown that pre-B ALL cells are highly motile in vitro, and migrate rapidly beneath layers of bone marrow stromal cells adherent to plastic. [12] [13] [14] This process is dependent on the adhesion molecules VLA-4 and VLA-5, which allow attachment of pre-B ALL cells to their ligands VCAM-1 and fibronectin within stroma. [12] [13] [14] Our results clearly indicate that the migration of pre-B ALL cells beneath layers of bone marrow fibroblasts is a selective process, since the microporous membrane system allowed cells that had Table 3 Inhibition of NALM-6 migration into BMF layer
13.5 ± 3.9** 2.1 ± 0.6** NT NT 2
19.1 ± 1.1 9.0 ± 1.9** NT NT NT 3 23.5 ± 2.0 3.4 ± 0.8* NT NT NT 4 28.8 ± 3.1 13.9 ± 2.2** 3.3 ± 0.7** 3.2 ± 0.4** NT 5 30.5 ± 0.6 20.0 ± 1.3** 5.2 ± 1.0** 5.2 ± 1.7** NT 6 27.3 ± 3.1 20.0 ± 0.2 NT NT 19.9 ± 0.1* 7 14.7 ± 2.7 5.6 ± 0.8** NT NT 10.1 ± 1.6 Mean ± s.d.
25.1 ± 6.2 12.2 ± 6.5** 3.5 ± 1.5** 4.2 ± 1.4** 15 ± 6.8
a Inhibition of migration of NALM-6 into BMF monolayer on plastic over 5 h. b Experiments 1 to 3 were done in triplicate wells, and experiments 4 to 7 in quadruplicate wells. Values represent mean % migration into BMF layers ± s.d. NALM-6 cells were pre-incubated with CXCR4, 4B4, or isotype control antibodies for 30 min before addition to BMF. Polyclonal rabbit anti-SDF-1 (20 g/ml) was added to BMF for 30 min prior to the addition of NALM-6 cells. *P р 0.05, comparison with isotype control. **P р 0.005, comparison with isotype control. NT, not tested.
Table 4
Inhibition of precursor-B ALL migration into BMF layer using CXCR4 antibody 11.0 ± 1.5 6.5 ± 2.6 40.9* 7 18.9 ± 2.6 14.0 ± 1.2 25.9* 8 17.2 ± 0.5 14.7 ± 0.3 14.5* 9
26.0 ± 1.4 24.0 ± 1.1 7.7
a Inhibition of precursor-B ALL migration into BMF monolayer on plastic over 5 h, using anti-CXCR4 antibody. b Case numbers identical to those in Table 2 . *P р 0.05 for comparison of anti-CXCR4 with isotype control.
penetrated underneath the BMF layer to continue to move into the lower chamber if their migration was completely nonselective. The fact that the BMF layer on the microporous membrane dramatically reduced recovery of leukemic cells in the lower chamber, together with the ultrastructural demonstration of pre-B ALL cells localized beneath the BMF layer, confirms that the leukemic cells have selectively 'homed' to this location. The second major finding is that SDF-1 is a chemokine for pre-B ALL cells, and may be an explanation, at least in part, for their localization under bone marrow stromal layers in vitro. We have shown that BMF produce m-RNA for SDF-1. Our findings demonstrate that pre-B ALL cells express the cellular receptor for SDF-1, namely CXCR4, 16, 17 and are stimulated to migrate across a microporous membrane along a concentration gradient of SDF-1. Migration of pre-B ALL cells into BMF layers could be partially inhibited by preincubation with a blocking antibody to the CXCR4 receptor, or by an inhibitory antibody to SDF-1. Furthermore, SDF-1 could induce a proportion of NALM-6 and precursor-B ALL cells to leave a BMF layer and move across a microporous membrane. Taken together, these data implicate SDF-1 as a factor regulating the motility of pre-B ALL cells in the marrow microenvironment.
Figure 4
Effects of SDF-1 on transmigration of NALM-6 across a microporous membrane. Transmigration of cells into lower chamber over 5 h; effects of SDF-1 in lower chamber at 100 and 200 ng/ml, respectively; SDF-1 at 100 ng/ml in lower chamber, NALM-6 pretreated with anti-CXCR4 antibody. Results indicate percentage of cells transmigrating +/− s.d., with experiments carried out in triplicate wells. *P р 0.05, comparison of SDF-1 with membrane; **P р 0.05, comparison of SDF(100)+Ab with SDF(100).
SDF-1 has already been shown to be a potent chemoattractant for human bone marrow progenitor cells, and can induce both chemotaxis and transendothelial migration of normal CD34 + cells and colony-forming cells. 18, 19, 21 Both normal CD34 + cells and leukemic blast cells from cases of acute myeloid leukemia (AML) have been demonstrated to express CXCR4, the cellular receptor for SDF-1. 21 Since it has been demonstrated that SDF-1 is produced in high concentrations by bone marrow stromal cells, it has been speculated that SDF-1 is an important regulator of stem cell homing and may be involved in clinically important processes such as stem cell mobilization. 19, 21 Although the marrow microenvironment has been shown to be critical in determining the fate of precursor-B ALL cells, 4, 5 no factors with definite chemotactic activity for human pre-B cells have been identified until recently. Despite the finding that B lymphopoiesis is grossly disrupted in mice lacking SDF-1, 20 there have been no reports of SDF-1 activity or CXCR4 receptor expression on normal or malignant human pre-B cells. However, recently Scheidweiler and colleagues 23 have reported that normal precursor B cells express CXCR4, and that SDF-1 was chemotactic for these cells. Our own findings extend these observations by demonstrating the presence of CXCR4 on the majority of cases of precursor-B ALL, as well as defining a functional role of SDF-1 in leukemic cell migration. Our data do not discriminate between potential chemokinetic (non-specific motility) and chemotactic (specific migration) effects of SDF-1, and more formal checkerboard studies would be required to establish this (eg Ref. 19 ). However, SDF-1 has been documented to have specific chemotactic activity on other human blood cell types, 19 and it is likely that the effects on precursor-B ALL migration observed in our study were also due to chemotaxis. Interestingly, we were unable to completely inhibit SDF-1 induced migration, either into a BMF layer, or out of a BMF layer into a SDF-1 gradient, using an inhibitory antibody to CXCR4, suggesting either that extremely high concentrations of SDF-1 exist within stromal layers in vitro, that other chemokines for pre-B ALL exist, or that SDF-1 binds to other receptors than CXCR4. It is relevant to note that Moehle and coworkers 21 also found that transendothelial migration of AML cells in response to a stromal cell conditioned medium containing SDF-1 was only partially blockable by an antibody to CXCR4, also suggesting that other chemokines or chemokine receptors may be involved in the motility of acute leukemia cells.
In conclusion, we have demonstrated that there is preferential localization of motile pre-B ALL cells within bone marrow stromal layers in vitro. While this requires the concordant expression of VLA-4 and VLA-5 to allow adhesion of the leukemic cells with stroma, SDF-1 appears to have significant chemotactic activity, and its secretion by stromal cells may be crucial in regulating the movement of ALL blasts within the bone marrow microenvironment. This may have considerable ramifications for influencing the subsequent proliferation and survival of ALL cells in vivo. Leukemia 
